| 0 (0%) | 11-11 15:57 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 10.95 |
1-year : | 11.97 |
| Resists | First : | 9.37 |
Second : | 10.25 |
| Pivot price | 8.62 |
|||
| Supports | First : | 7.96 |
Second : | 6.63 |
| MAs | MA(5) : | 8.31 |
MA(20) : | 8.79 |
| MA(100) : | 9.8 |
MA(250) : | 16 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 12 |
D(3) : | 13.1 |
| RSI | RSI(14): 41.4 |
|||
| 52-week | High : | 28.7 | Low : | 7.55 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ CPSI ] has closed above bottom band by 22.8%. Bollinger Bands are 34% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 8.32 - 8.37 | 8.37 - 8.42 |
| Low: | 7.84 - 7.9 | 7.9 - 7.97 |
| Close: | 8.17 - 8.28 | 8.28 - 8.38 |
Fri, 16 May 2025
Infant undergoes first ever gene editing therapy, treats rare CPSI deficiency - financialexpress.com
Thu, 15 May 2025
Nine-month-old becomes first person to be cured via personal gene-editing treatment - Peoples Gazette Nigeria
Tue, 10 Dec 2024
Crime Analysis Centers Managed by RIT’s CPSI Helped Reduce Gun Violence, Earned Award - Rochester Institute of Technology
Tue, 23 Apr 2024
CPSI completes acquisition of Healthland - McKnight's Long-Term Care News
Tue, 23 Apr 2024
CPSI to buy Get Real Health - McKnight's Long-Term Care News
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 15 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 4.4 (%) |
| Held by Institutions | 91.6 (%) |
| Shares Short | 461 (K) |
| Shares Short P.Month | 268 (K) |
| EPS | -0.06 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.14 |
| Profit Margin | -13.5 % |
| Operating Margin | -4.2 % |
| Return on Assets (ttm) | -0.7 % |
| Return on Equity (ttm) | -21.9 % |
| Qtrly Rev. Growth | 3.2 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 23.39 |
| EBITDA (p.s.) | 0.96 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1 (M) |
| Levered Free Cash Flow | -38 (M) |
| PE Ratio | -165.6 |
| PEG Ratio | -0.6 |
| Price to Book value | 0.63 |
| Price to Sales | 0.35 |
| Price to Cash Flow | 113.34 |
| Dividend | 0.1 |
| Forward Dividend | 0 |
| Dividend Yield | 1.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|